Patents by Inventor Kenneth T. Holeva

Kenneth T. Holeva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969451
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid and/or mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: April 30, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11969454
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: April 30, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11931331
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: March 19, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11878042
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: January 23, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T Holeva
  • Patent number: 11878041
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: November 1, 2021
    Date of Patent: January 23, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11806327
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: November 7, 2023
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
  • Publication number: 20220378858
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Application
    Filed: May 5, 2022
    Publication date: December 1, 2022
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11357805
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: June 14, 2022
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Publication number: 20220087965
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Application
    Filed: December 1, 2021
    Publication date: March 24, 2022
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
  • Publication number: 20220062424
    Abstract: The present invention relates to compositions providing improved preservative efficacy. The present invention further relates to polyquaternium compound containing compositions having improved the antifungal activity. In certain embodiments, the present invention relates to ophthalmic compositions comprising a polyquaternium compound, a polyol or combination of polyols, borate compound, and an antimicrobial mixture comprising electrolytes and nutrients.
    Type: Application
    Filed: November 9, 2021
    Publication date: March 3, 2022
    Inventors: Mingqi Bai, Kenneth T. Holeva
  • Publication number: 20220047657
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Application
    Filed: November 1, 2021
    Publication date: February 17, 2022
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Publication number: 20210401919
    Abstract: The present invention relates to compositions providing improved substantivity, comfort and/or feel to the eye upon application. The present invention further relates to compositions comprising a cellulose derivative in combination with tamarind seed extract and hyaluronic acid in ratios that mimic the physical properties of human tears on the eye.
    Type: Application
    Filed: September 7, 2021
    Publication date: December 30, 2021
    Inventors: Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11202832
    Abstract: The present invention relates to compositions providing improved preservative efficacy. The present invention further relates to polyquaternium compound containing compositions having improved the antifungal activity. In certain embodiments, the present invention relates to ophthalmic compositions comprising a polyquaternium compound, a polyol or combination of polyols, borate compound, and an antimicrobial mixture comprising electrolytes and nutrients.
    Type: Grant
    Filed: March 4, 2020
    Date of Patent: December 21, 2021
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11197841
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: December 14, 2021
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11166997
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: November 9, 2021
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11129862
    Abstract: The present invention relates to compositions providing improved substantivity, comfort and/or feel to the eye upon application. The present invention further relates to compositions comprising a cellulose derivative in combination with tamarind seed extract and hyaluronic acid in ratios that mimic the physical properties of human tears on the eye.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: September 28, 2021
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Mingqi Bai, Kenneth T. Holeva
  • Publication number: 20210186913
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Application
    Filed: March 1, 2021
    Publication date: June 24, 2021
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
  • Publication number: 20210145916
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Application
    Filed: November 16, 2020
    Publication date: May 20, 2021
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
  • Publication number: 20210145909
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid and/or mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Application
    Filed: November 16, 2020
    Publication date: May 20, 2021
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 10966948
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: April 6, 2021
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva